| For: | Gkolfinopoulos S, Tsapakidis K, Papadimitriou K, Papamichael D, Kountourakis P. Chromogranin A as a valid marker in oncology: Clinical application or false hopes? World J Methodol 2017; 7(1): 9-15 [PMID: 28396845 DOI: 10.5662/wjm.v7.i1.9] |
|---|---|
| URL: | https://www.wjgnet.com/2222-0682/full/v7/i1/9.htm |
| Number | Citing Articles |
| 1 |
Matthew Sanborn, Alisha Maity, Vladimir Limmonick, Aqeel Siddiqui, Steven Salvatore, Terri McHugh . Chromogranin A-Associated Tubulopathy in a Patient With Neuroendocrine Tumor. Cureus 2025; doi: 10.7759/cureus.99048
|
| 2 |
Shadin Ghabra, Tracey Pu, Naris Nilubol, Andrew Mannes, Ning Miao. Anesthesia for Oncological Surgery. 2023; doi: 10.1007/978-3-031-50977-3_52
|
| 3 |
Kristin Henry. Paraneoplastic syndromes: Definitions, classification, pathophysiology and principles of treatment. Seminars in Diagnostic Pathology 2019; 36(4) doi: 10.1053/j.semdp.2019.01.002
|
| 4 |
Wei-Yu Chen, Phan Vu Thuy Dung, Hsiu-Lien Yeh, Wei-Hao Chen, Kuo-Ching Jiang, Han-Ru Li, Zi-Qing Chen, Michael Hsiao, Jiaoti Huang, Yu-Ching Wen, Yen-Nien Liu. Targeting PKLR/MYCN/ROMO1 signaling suppresses neuroendocrine differentiation of castration-resistant prostate cancer. Redox Biology 2023; 62 doi: 10.1016/j.redox.2023.102686
|
| 5 |
Anassuya Ramachandran, Ben Lawrence. Neuroendocrine Neoplasia. Endocrinology 2025; doi: 10.1007/978-3-031-83281-9_5
|
| 6 |
Annamária Kövesdi, Petra Anna Kurucz, Gábor Nyírő, Ottó Darvasi, Attila Patócs, Henriett Butz. Circulating miRNA Increases the Diagnostic Accuracy of Chromogranin A in Metastatic Pancreatic Neuroendocrine Tumors. Cancers 2020; 12(9) doi: 10.3390/cancers12092488
|
| 7 |
Adam Daniel Durma, Marek Saracyn, Katarzyna Jóźwik-Plebanek, Dorota Brodowska-Kania, Maciej Kołodziej, Wawrzyniec Żmudzki, Grzegorz Kamiński. Complications and outcomes of radioligand therapy in patients with neuroendocrine neoplasms depending on the baseline glomerular filtration rate. European Journal of Nuclear Medicine and Molecular Imaging 2025; 53(1) doi: 10.1007/s00259-025-07418-5
|
| 8 |
Helen L. Robbins, Megan Symington, Barbara Mosterman, Fiona Tranter, Louise Davies, Harpal S. Randeva, Ana Penedo, Clara Ferreira, Catherine Darby, Dimitri Grammatopoulos, Gregory Kaltsas, Martin O. Weickert. Effects of intake of breakfast or caffeine-containing beverages on measurement of circulating chromogranin A in plasma. GastroHep 2019; 1(1) doi: 10.1002/ygh2.208
|
| 9 |
Hussein Qasim, Shaima' Dibian, Mohammad Abu Shugaer, Karis Khattab, Mudhaffer Touqan, Matteo Luigi Giuseppe Leoni , Giustino Varrassi. Neuroendocrine Neoplasms of the Gastrointestinal Tract: Morphology, WHO 2022 Grading, and Prognostic Perspectives. Cureus 2026; doi: 10.7759/cureus.100913
|
| 10 |
Anja C. Roden, Julian R. Molina. Plasma Biomarkers to Monitor Bronchopulmonary Carcinoids—Are We There Yet?. Journal of Thoracic Oncology 2023; 18(3) doi: 10.1016/j.jtho.2022.12.008
|
| 11 |
Ananya Panda, Malak Itani, Joyce Mhlanga, Charanjeet Singh, Onofrio Antonio Catalano, Chandana Lall, Hina Arif-Tiwari, Linda Chu. Pancreatic Neuroendocrine Neoplasms. Seminars in Ultrasound, CT and MRI 2026; doi: 10.1053/j.sult.2026.06.001
|
| 12 |
Michele Bevere, Francesca Masetto, Maria Elena Carazzolo, Alice Bettega, Anastasios Gkountakos, Aldo Scarpa, Michele Simbolo. An Overview of Circulating Biomarkers in Neuroendocrine Neoplasms: A Clinical Guide. Diagnostics 2023; 13(17) doi: 10.3390/diagnostics13172820
|
| 13 |
Marlena Budek, Jarosław Nuszkiewicz, Jolanta Czuczejko, Marta Maruszak-Parda, Joanna Wróblewska, Jakub Wojtasik, Iga Hołyńska-Iwan, Marta Pawłowska, Alina Woźniak, Karolina Szewczyk-Golec. Searching for New Biomarkers of Neuroendocrine Tumors: A Comparative Analysis of Chromogranin A and Inflammatory Cytokines in Patients with Neuroendocrine Tumors. Current Oncology 2024; 31(10) doi: 10.3390/curroncol31100456
|
| 14 |
T Szarvas, B Jardin-Watelet, N Bourgoin, M J Hoffmann, P Nyirády, C Oláh, T Széll, A Csizmarik, B Hadaschik, H Reis. High-soluble CGA levels are associated with poor survival in bladder cancer. Endocrine Connections 2019; 8(5) doi: 10.1530/EC-19-0068
|
| 15 |
Sultan Ahmed, Ayaz Gen, Abu Fahad Abbasi, Saad Rashid, Sanya Siraj, Altaf Dawood, Yoshifumi Nakayama. A Challenging Decision: Identifying and Managing Hepatic Hydrothorax in the Setting of a Pancreatic Neuroendocrine Tumor. Case Reports in Gastrointestinal Medicine 2025; 2025(1) doi: 10.1155/crgm/9397326
|
| 16 |
Salman Syed, Spyridon P. Basourakos, Faisal S. Ali, Jessica L. Garcia, Amado Zurita-Saavedra, Zimu Gong. A Limited-Versus-Extensive Staging Strategy for Small Cell Prostate Cancer. American Journal of Clinical Oncology 2020; 43(2) doi: 10.1097/COC.0000000000000631
|
| 17 |
Jack Cope, Rory Maclean, Shweta Hota, John K. Ramage, Nicola Mullholland, Dominique Clement, Sarah Brown, Sue Piper, Phil MaCarthy, Olaf Wendler, Raj Srirajaskanthan. Improving outcomes in carcinoid heart disease – learning from a single centre. Nuclear Medicine Communications 2023; 44(11) doi: 10.1097/MNM.0000000000001749
|
| 18 |
Diana Loreta Paun, Alexandra Mirica. Pheochromocytoma, Paraganglioma and Neuroblastoma. 2021; doi: 10.5772/intechopen.95888
|
| 19 |
|
| 20 |
Zhou K, Aniqa Faraz Crossville, Hendrixson M. A rare case of pancreatic mixed acinar-neuroendocrine carcinoma. Journal of Case Reports and Images in Oncology 2024; 10(2) doi: 10.5348/100138Z10ZK2024CR
|
| 21 |
Ambreen A. Merchant, Anna M. Goebel, Field F. Willingham. Radiofrequency ablation for the management of pancreatic mass lesions. Current Opinion in Gastroenterology 2023; 39(5) doi: 10.1097/MOG.0000000000000939
|
| 22 |
Thorvardur R. Halfdanarson, Jonathan R. Strosberg, Laura Tang, Andrew M. Bellizzi, Emily K. Bergsland, Thomas M. O'Dorisio, Daniel M. Halperin, Lauren Fishbein, Jennifer Eads, Thomas A. Hope, Simron Singh, Riad Salem, David C. Metz, Boris G. Naraev, Diane L. Reidy-Lagunes, James R. Howe, Rodney F. Pommier, Yusuf Menda, Jennifer A. Chan. The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Pancreatic Neuroendocrine Tumors. Pancreas 2020; 49(7) doi: 10.1097/MPA.0000000000001597
|
| 23 |
Joyce Cheng, Ghanshyam Patel , Altaf Dawood, Ammar Aqeel. Gastric and Duodenal Neuroendocrine Tumor Incidentally Found on Endoscopy During the Evaluation of Iron-Deficiency Anemia. Cureus 2022; doi: 10.7759/cureus.22208
|
| 24 |
Kentaro Taniguchi, Akitoshi Seiyama. Salivary chromogranin a reflects autonomic regulation during “wake to sleep” and “sleep to wake” transitions. Bulletin of the National Research Centre 2025; 49(1) doi: 10.1186/s42269-025-01340-4
|
| 25 |
Akeem R. Lewis, Brian A. Costello, Fernando Quevedo, Lance C. Pagliaro, Cristobal Sanhueza, Richard M. Weinshilboum, Krishna R. Kalari, Liewei Wang, Manish Kohli, Winston Tan, Karthik V. Giridhar. Dynamic assessment of serum chromogranin A and treatment response with abiraterone acetate in metastatic castration‐resistant prostate cancer. The Prostate 2023; 83(7) doi: 10.1002/pros.24498
|
| 26 |
Halyna Chytaieva . Correlation between expression of immunohistochemical markers and morphology in lung neuroendocrine neoplasms. The Ukrainian Scientific Medical Youth Journal 2022; 128(1) doi: 10.32345/USMYJ.1(128).2022.6-18
|
| 27 |
Valentina Caputo, Franco Rongioletti. Primary Epithelioid Angiosarcoma of the Penis With Aberrant Expression of Synaptophysin: A Case Report and Review of Diagnostic Pitfalls. Journal of Cutaneous Pathology 2026; 53(3) doi: 10.1111/cup.70031
|
| 28 |
Karthik V. Giridhar, Cristobal Sanhueza, David W Hillman, Hassan Alkhateeb, Rachel Carlson, Winston Tan, Brian A. Costello, Fernando Quevedo, Lance Pagliaro, Manish Kohli. Serum chromogranin-A-based prognosis in metastatic castration-resistant prostate cancer. Prostate Cancer and Prostatic Diseases 2018; 21(3) doi: 10.1038/s41391-018-0046-9
|
| 29 |
Ko‐Chao Lee, Hong‐Hwa Chen, Kung‐Chuan Cheng, Ting‐Ting Liu, Kam‐Fai Lee, Chih‐Chuan Teng, Cheng‐Yi Huang, Meng‐Chiao Hsieh, Hsing‐Chun Kuo. Use of iTRAQ‐based quantitative proteomic identification of CHGA and UCHL1 correlated with lymph node metastasis in colorectal carcinoma. Journal of Cellular and Molecular Medicine 2023; 27(14) doi: 10.1111/jcmm.17793
|
| 30 |
Antoine Hollebecque, Stefania Salvagni, Ruth Plummer, Patricia Niccoli, Jaume Capdevila, Giuseppe Curigliano, Victor Moreno, Filippo de Braud, Sonia Gonzalez de Villambrosia, Patricia Martin‐Romano, Eric Baudin, Marina Arias, Juan de Alvaro, Josep L. Parra‐Palau, Tania Sánchez‐Pérez, Ida Aronchik, Ellen H. Filvaroff, Manisha Lamba, Zariana Nikolova, Johann S. de Bono. Clinical activity of CC‐90011, an oral, potent, and reversible LSD1 inhibitor, in advanced malignancies. Cancer 2022; 128(17) doi: 10.1002/cncr.34366
|
| 31 |
K. Öberg, A. Califano, J.R. Strosberg, S. Ma, U. Pape, L. Bodei, G. Kaltsas, C. Toumpanakis, J.R. Goldenring, A. Frilling, S. Paulson. A meta-analysis of the accuracy of a neuroendocrine tumor mRNA genomic biomarker (NETest) in blood. Annals of Oncology 2020; 31(2) doi: 10.1016/j.annonc.2019.11.003
|
| 32 |
Elyse C. Wyatt, Eric L. Wyatt, Robbie L. Graham. Sweat gland carcinoma with neuroendocrine differentiation of the scalp with elevated serum chromogranin A levels. JAAD Case Reports 2025; 60 doi: 10.1016/j.jdcr.2024.12.002
|
| 33 |
Shane Quo, Wisam Zakko. A Case of Functional Bowel Disease Misdiagnosed as Carcinoid Syndrome. ACG Case Reports Journal 2023; 10(9) doi: 10.14309/crj.0000000000001136
|
| 34 |
Ivaylo Stefanov Stefanov, Stefan Ivaylov Stefanov, Maya Vladova Gulubova. Glucagon- and insulin-immunopositive endocrine cells in porcine extrahepatic bile ducts and gallbladder. Frontiers in Veterinary Science 2023; 10 doi: 10.3389/fvets.2023.1240143
|
| 35 |
Jaume Trapé, Esther Fernández-Galán, Josep Maria Auge, Marina Carbonell-Prat, Xavier Filella, Sílvia Miró-Cañís, Carolina González-Fernández. Factors influencing blood tumor marker concentrations in the absence of neoplasia. Tumor Biology 2024; 46(s1) doi: 10.3233/TUB-220023
|
| 36 |
Kade C. Flowers, Kate E. Shipman. Pitfalls in the Diagnosis and Management of Hypercortisolism (Cushing Syndrome) in Humans; A Review of the Laboratory Medicine Perspective. Diagnostics 2023; 13(8) doi: 10.3390/diagnostics13081415
|
| 37 |
Grace Kong, Geertje Noe, Cherie Chiang, Ken Herrmann, Thomas A. Hope, Michael Michael. Assessment of response to PRRT including anatomical and molecular imaging as well as novel biomarkers. Journal of Neuroendocrinology 2025; 37(3) doi: 10.1111/jne.13461
|
| 38 |
Anassuya Ramachandran, Ben Lawrence. Neuroendocrine Neoplasia. Endocrinology 2026; doi: 10.1007/978-3-030-67823-4_5-1
|
| 39 |
Sarath S. Joseph, Dan H. V. Tran, Farhadul Islam, Vinod Gopalan. Current Cancer Biomarkers. 2023; doi: 10.2174/9789815079364123010011
|
| 40 |
Oana Ciobanu, Sorina Martin, Simona Fica. Perspectives on the diagnostic, predictive and prognostic markers of neuroendocrine neoplasms (Review). Experimental and Therapeutic Medicine 2021; 22(6) doi: 10.3892/etm.2021.10914
|
| 41 |
Oksana Novikova, Olga Sidorenko, Galina Bozhok, Tatyana Bondarenko. Cryopreservation Effect on Chromogranin A Expression in Neonatal Pig Adrenal Cell Culture. Problems of Cryobiology and Cryomedicine 2019; 29(4) doi: 10.15407/cryo29.04.344
|
| 42 |
Hossein Yahyazadeh, Marzieh Beheshti, Sahel Valadan Tahbaz. Gastrointestinal Neuroendocrine Tumours: A Single-Centre Experience. Forum of Clinical Oncology 2022; 13(1) doi: 10.2478/fco-2022-0004
|
| 43 |
N. V. Lyubimova, Yu. S. Timofeev, T. K. Churikova, A. A. Markovich, G. S. Emelianova, I. S. Stilidi, N. E. Kushlinskii. Chromogranin A and serotonin for evaluation of treatment efficacy of neuroendocrine tumors. Almanac of Clinical Medicine 2020; 47(8) doi: 10.18786/2072-0505-2019-47-054
|
| 44 |
Salmaan Sayeed, Danielle Kapustin, Samuel J. Rubin, Jun Fan, Christina Wiedmer, Daniel Chung, Azita Khorsandi, Margaret Brandwein-Weber, Philip Friedlander, Richard Bakst, Ricardo J. Ramirez, Mark L. Urken. Metastatic merkel cell carcinoma to the thyroid gland: Case report and review of the literature. American Journal of Otolaryngology 2024; 45(4) doi: 10.1016/j.amjoto.2024.104278
|
| 45 |
Juliette M Kassas, Julia V Fiuk, Carol A Brenner. Primary Small Cell Carcinoma of the Bladder. Cureus 2021; doi: 10.7759/cureus.15146
|
| 46 |
Anna Malczewska, Mark Kidd, Somer Matar, Beata Kos-Kudła, Lisa Bodei, Kjell Oberg, Irvin M. Modlin. An Assessment of Circulating Chromogranin A as a Biomarker of Bronchopulmonary Neuroendocrine Neoplasia: A Systematic Review and Meta-Analysis. Neuroendocrinology 2020; 110(3-4) doi: 10.1159/000500525
|
| 47 |
Hossein Safarpour, Javad Ranjbaran, Nafiseh Erfanian, Samira Nomiri, Afshin Derakhshani, Casimiro Gerarduzzi, Adib Miraki Feriz, Edris HosseiniGol, Samira Saghafi, Nicola Silvestris. Holistic exploration of CHGA and hsa-miR-137 in colorectal cancer via multi-omic data Integration. Heliyon 2024; 10(5) doi: 10.1016/j.heliyon.2024.e27046
|
| 48 |
Eshwari Dathathri, Fikri Abali, Michiel Stevens, Richell Booijink, Tanja C. van Dijk, Khrystany T. Isebia, John W.M. Martens, Jaco Kraan, Nick Beije, Martijn P. Lolkema, Peter A.W. te Boekhorst, Paul Hamberg, Brigitte C.M. Haberkorn, Danny Houtsma, Joan van den Bosch, Wendy M. van der Deure, Ruchi Bansal, Leon W.M.M. Terstappen. PSA Secretion from Single Circulating Tumor Cells of Metastatic Castration-Naïve Prostate Cancer Patients. Cancer Research Communications 2025; 5(8) doi: 10.1158/2767-9764.CRC-25-0158
|
| 49 |
Matthew Philip Davies, Thomas William John Evans, Fawzia Tahir, Saba P. Balasubramanian. Parathyroid cancer: A systematic review of diagnostic biomarkers. The Surgeon 2021; 19(6) doi: 10.1016/j.surge.2021.01.011
|